RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sana Ali

Los Angeles, CANPI 1841819349

Payments from drug & device makers

$2,908in general payments, 2019–2025

Across 106 payments — averaging $27.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$558
  • AbbVie$345
  • AstraZeneca$287
  • Sanofi$204
  • Incyte Corporation$200
  • Johnson & Johnson$182
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,73894%
  • Education$1706%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis20$558
AbbVie11$345
AstraZeneca(2 entities)12$287
Sanofi7$204
Incyte Corporation7$200
Johnson & Johnson6$182
EMD Serono, Inc.5$160
Bristol Myers Squibb5$138
Merck5$133
Daiichi Sankyo Inc.4$105
Pfizer3$82
Servier Pharmaceuticals LLC3$73
Gilead2$62
Karyopharm Therapeutics Inc.2$54
Genentech USA, Inc.2$51
E.r. Squibb & Sons, L.L.C.3$50
Agios Pharmaceuticals, Inc.2$47
Blueprint Medicines Corporation2$43
Syndax Pharmaceuticals, Inc.1$32
Puma Biotechnology, Inc.1$30
Kyowa Kirin, Inc.1$29
Deciphera Pharmaceuticals Inc.1$22
Coherus Oncology, Inc.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →